Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reliant Immune Diagnostics is a private healthcare technology company focused on consumer-driven telehealth and at-home diagnostics. The company operates the MDBox platform, which combines telemedicine visits, self-administered diagnostic testing, AI and machine learning-enabled decision support, and personal health data tracking. Public descriptions of the business emphasize testing, diagnosing, and monitoring solutions delivered through a digital front end rather than a traditional therapeutic drug pipeline. Reliant has also described work on rapid diagnostic tools and image analysis capabilities intended to support remote care. The company appears to be operating commercially as a digital health and diagnostics platform rather than as a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reliant Immune Diagnostics.